Woodline Partners’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $976K | Buy |
567,680
+765
| +0.1% | +$1.32K | 0.01% | 806 |
|
|
2025
Q1 | $1.89M | Buy |
566,915
+3,338
| +0.6% | +$11.1K | 0.01% | 673 |
|
|
2024
Q4 | $4.17M | Buy |
563,577
+1,142
| +0.2% | +$8.45K | 0.03% | 522 |
|
|
2024
Q3 | $5.28M | Buy |
+562,435
| New | +$5.28M | 0.04% | 381 |
|
|
2024
Q2 | – | Sell |
-1,482,859
| Closed | -$22M | – | 611 |
|
|
2024
Q1 | $22M | Sell |
1,482,859
-121,847
| -8% | -$1.81M | 0.2% | 154 |
|
|
2023
Q4 | $13M | Buy |
1,604,706
+958,411
| +148% | +$7.79M | 0.14% | 201 |
|
|
2023
Q3 | $2.94M | Buy |
+646,295
| New | +$2.94M | 0.03% | 365 |
|
|
2022
Q4 | – | Sell |
-261,134
| Closed | -$2.5M | – | 800 |
|
|
2022
Q3 | $2.5M | Sell |
261,134
-238,636
| -48% | -$2.29M | 0.04% | 430 |
|
|
2022
Q2 | $5.52M | Buy |
499,770
+312,906
| +167% | +$3.45M | 0.09% | 246 |
|
|
2022
Q1 | $3.11M | Sell |
186,864
-431,839
| -70% | -$7.19M | 0.05% | 306 |
|
|
2021
Q4 | $11.8M | Buy |
618,703
+433,151
| +233% | +$8.27M | 0.17% | 163 |
|
|
2021
Q3 | $4.58M | Buy |
+185,552
| New | +$4.58M | 0.07% | 264 |
|
|
2021
Q2 | – | Sell |
-277,523
| Closed | -$8.79M | – | 611 |
|
|
2021
Q1 | $8.79M | Buy |
277,523
+255,949
| +1,186% | +$8.1M | 0.19% | 134 |
|
|
2020
Q4 | $1M | Sell |
21,574
-177,110
| -89% | -$8.22M | 0.03% | 209 |
|
|
2020
Q3 | $6.54M | Buy |
+198,684
| New | +$6.54M | 0.21% | 110 |
|
|
2020
Q2 | – | Sell |
-280,498
| Closed | -$8.4M | – | 167 |
|
|
2020
Q1 | $8.4M | Buy |
280,498
+137,857
| +97% | +$4.13M | 0.6% | 58 |
|
|
2019
Q4 | $3.95M | Buy |
+142,641
| New | +$3.95M | 0.16% | 97 |
|